ClinicalTrials.gg
RecruitingNCT06319703IDEALUpdated Mar 9, 2026

Implementing an Effective Diabetes Intervention Among Low-Income Immigrants

An interventional study of Diabetes Self-Management Education and Support (DSMES) Videos and Community Health Worker Support (CHW) in Type 2 Diabetes, sponsored by NYU Langone Health. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-03-09.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Health services research

How we know · 2 judgments

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
270
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Diabetes Mellitus, Type 2 by NYU Langone Health — 6 open to participants now, 6 under way, none of them phase 3. Diabetes Mellitus, Type 2 · NYU Langone Health.

Planned enrollment
6th of 23
270 · median 100
Started
2024
with 2 others
No phase
20 of 25
6 open now
Registered
21st of 25
by date

Among the 25 studies in Diabetes Mellitus, Type 2 by NYU Langone Health, this one is the 6th largest by planned enrollment of the 23 interventional ones that give a count, is one of 3 that started in 2024, is one of 20 with no phase, and was the 21st registered.

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

6 of the 25 studies in Diabetes Mellitus, Type 2 by NYU Langone Health are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Diabetes Mellitus, Type 2 by NYU Langone Health, or all of them as a file.
02

Study summary

The goal of this IDEAL project is to examine the effectiveness and implementation process of the video-based Diabetes Self-Management Education and Support (DSMES) + community health worker (CHW) (hereafter: "IDEAL") intervention compared with a wait-list control group (hereafter: "CONTROL") to improve glycemic control among Chinese immigrants with Type 2 diabetes (T2D) in New York City (NYC). Participants will be randomized with equal allocation to one of the 2 groups. The IDEAL group will receive 1 DSMES brief video/week for 24 weeks delivered via text message. The CHW will assess participants' SDOH barriers to T2D care and link them to available resources in the community. The CONTROL group will continue to receive their usual care and at the end of the study, they will receive DSMES videos.

03

Conditions studied

  • Type 2 Diabetes

Keywords

  • Mobile Health
  • mHealth
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants must:

  1. self-identify as a Chinese immigrant;
  2. be between 18-70 years old,
  3. have a diagnosis of T2D in the medical record;
  4. have had an appointment with a physician for routine T2D care within the past 12 months;
  5. have a most recent > or = 8%;
  6. be willing to receive brief videos regarding T2D management, and
  7. possess a smartphone or, if they do not have one, be willing and able to use a study smartphone.

Exclusion criteria

Exclusion Criteria:

  1. unable or unwilling to provide ;
  2. unable to participate meaningfully in the intervention (e.g., uncorrected sight and hearing impairment);
  3. unwilling to accept randomization assignment;
  4. is pregnant, plans to become pregnant in the next 6 months, or becomes pregnant during the study, or
  5. is breastfeeding (e.g., they may have potential dietary restrictions).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
270 participants (estimated)

Study arms

  • Experimental
    DSMES+CHW (IDEAL)

    Participants in this group will receive brief pre-recorded DSMES videos, which include both educational and Social Cognitive Theory-based behavioral content. Participants will receive 1 DSMES video via text message each week for a total of 24 weeks with each video lasting about 5 minutes in duration. In addition, they will also receive brief phone calls from CHWs every 2 weeks during the 24 weeks video program. During these calls, CHWs will assess whether participants need assistance on social determinants of health (SDOH) barriers. If needed, CHWs will link participants to available services within the community. CHWs will also provide assistance on navigating the complex health care systems and serve as an advocate for patients during doctor visits if needed.

    Behavioral: Diabetes Self-Management Education and Support (DSMES) Videos · Behavioral: Community Health Worker Support (CHW)

  • No intervention
    Wait-list control group (CONTROL)

    Participants in this group will continue to receive the standard of usual care for their T2D at their doctor's office during the course of our study.

Interventions

  • BehavioralDiabetes Self-Management Education and Support (DSMES) Videos

    Text message-delivered video-based DSMES intervention.

  • BehavioralCommunity Health Worker Support (CHW)

    Assess participants' SDOH barriers to Type 2 diabetes care and link them to available resources in the community.

06

What researchers measure

Primary outcomes

  1. Change in Hemoglobin A1C (HbA1c) Test Scores

    Scores expressed as a percentage of red blood cells that have sugar-coated hemoglobin. Patients with Type 2 Diabetes receive a HbA1c blood test at their doctors' office every 3-6 months as part of usual care; testing results will be abstracted from the medical record at the participant's health care facility to minimize participant burden.

    Time frame: Baseline, Month 6

  2. Change in Hemoglobin A1C (HbA1c) Test Scores

    Scores expressed as a percentage of red blood cells that have sugar-coated hemoglobin. Patients with Type 2 Diabetes receive a HbA1c blood test at their doctors' office every 3-6 months as part of usual care; testing results will be abstracted from the medical record at the participant's health care facility to minimize participant burden.

    Time frame: Baseline, Month 12

Secondary outcomes

  1. Stanford Self-Efficacy for Diabetes Scale Score

    8-item self-assessment of participants' confidence level in performing specific self-management behaviors. Items are ranked on a 10-point Likert scale ranging from 1 (not at all confident) to 10 (totally confident). The score is the mean of the 8 items (Range: 1-10); higher scores indicate greater self-efficacy.

    Time frame: Baseline

  2. Stanford Self-Efficacy for Diabetes Scale Score

    8-item self-assessment of participants' confidence level in performing specific self-management behaviors. Items are ranked on a 10-point Likert scale ranging from 1 (not at all confident) to 10 (totally confident). The score is the mean of the 8 items (Range: 1-10); higher scores indicate greater self-efficacy.

    Time frame: Month 6

  3. Stanford Self-Efficacy for Diabetes Scale Score

    8-item self-assessment of participants' confidence level in performing specific self-management behaviors. Items are ranked on a 10-point Likert scale ranging from 1 (not at all confident) to 10 (totally confident). The score is the mean of the 8 items (Range: 1-10); higher scores indicate greater self-efficacy.

    Time frame: Month 12

  4. Summary of Diabetes Self-Care Activities (SDSCA) Score

    11-item self-report questionnaire assessing participants' adherence to diabetes self-management behaviors. Participants select the number of days (0 to 7) in the past week they have performed the behavior. The result is an average score between 0 and 7; higher scores indicate better diabetes self-management behavior.

    Time frame: Baseline

  5. Summary of Diabetes Self-Care Activities (SDSCA) Score

    11-item self-report questionnaire assessing participants' adherence to diabetes self-management behaviors. Participants select the number of days (0 to 7) in the past week they have performed the behavior. The result is an average score between 0 and 7; higher scores indicate better diabetes self-management behavior.

    Time frame: Month 6

  6. Summary of Diabetes Self-Care Activities (SDSCA) Score

    11-item self-report questionnaire assessing participants' adherence to diabetes self-management behaviors. Participants select the number of days (0 to 7) in the past week they have performed the behavior. The result is an average score between 0 and 7; higher scores indicate better diabetes self-management behavior.

    Time frame: Month 12

  7. Starting the Conversation (STC) Diet Scale Score

    8-item self-report questionnaire measuring dietary behaviors. Scores range from 0 to 16; higher scores indicate more dietary behaviors that are not consistent with health.

    Time frame: Baseline

  8. Starting the Conversation (STC) Diet Scale Score

    8-item self-report questionnaire measuring dietary behaviors. Scores range from 0 to 16; higher scores indicate more dietary behaviors that are not consistent with health.

    Time frame: Month 6

  9. Starting the Conversation (STC) Diet Scale Score

    8-item self-report questionnaire measuring dietary behaviors. Scores range from 0 to 16; higher scores indicate more dietary behaviors that are not consistent with health.

    Time frame: Month 12

  10. National Cancer Institute Dietary Screener Questionnaire Score

    27-item self-assessment of frequency of consumption of selected foods and drinks over the past month. The scoring procedure converts responses to estimates of individual dietary intake for: Fruits and Vegetables (cup equivalents); Dairy (cup equivalents); Added Sugars (teaspoon equivalents); Whole Grains (ounce equivalents); Fiber (grams); and Calcium (milligrams). Higher scores indicate higher consumption of the food item.

    Time frame: Baseline

  11. National Cancer Institute Dietary Screener Questionnaire Score

    27-item self-assessment of frequency of consumption of selected foods and drinks over the past month. The scoring procedure converts responses to estimates of individual dietary intake for: Fruits and Vegetables (cup equivalents); Dairy (cup equivalents); Added Sugars (teaspoon equivalents); Whole Grains (ounce equivalents); Fiber (grams); and Calcium (milligrams). Higher scores indicate higher consumption of the food item.

    Time frame: Month 6

  12. National Cancer Institute Dietary Screener Questionnaire Score

    27-item self-assessment of frequency of consumption of selected foods and drinks over the past month. The scoring procedure converts responses to estimates of individual dietary intake for: Fruits and Vegetables (cup equivalents); Dairy (cup equivalents); Added Sugars (teaspoon equivalents); Whole Grains (ounce equivalents); Fiber (grams); and Calcium (milligrams). Higher scores indicate higher consumption of the food item.

    Time frame: Month 12

  13. International Physical Activity Questionnaire (IPAQ) Short-Version Score

    Self-assessment providing an estimate of the number of minutes per week participants engage in three categories of physical activity: vigorous activity, moderate activity, and walking activity. Results are expressed in metabolic equivalent (MET) minutes per week. MET minutes represent the amount of energy expended carrying out physical activity. The formula for calculating MET is as follows: 8(vigorous activity)(minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes) = MET. Higher scores indicate higher weekly levels of physical activity.

    Time frame: Baseline

  14. International Physical Activity Questionnaire (IPAQ) Short-Version Score

    Self-assessment providing an estimate of the number of minutes per week participants engage in three categories of physical activity: vigorous activity, moderate activity, and walking activity. Results are expressed in metabolic equivalent (MET) minutes per week. MET minutes represent the amount of energy expended carrying out physical activity. The formula for calculating MET is as follows: 8(vigorous activity)(minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes) = MET. Higher scores indicate higher weekly levels of physical activity.

    Time frame: Month 6

  15. International Physical Activity Questionnaire (IPAQ) Short-Version Score

    Self-assessment providing an estimate of the number of minutes per week participants engage in three categories of physical activity: vigorous activity, moderate activity, and walking activity. Results are expressed in metabolic equivalent (MET) minutes per week. MET minutes represent the amount of energy expended carrying out physical activity. The formula for calculating MET is as follows: 8(vigorous activity)(minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes) = MET. Higher scores indicate higher weekly levels of physical activity.

    Time frame: Month 12

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to: Lu.hu@nyulangone.org. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

Time frame: Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.

Access criteria: The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to Lu.hu@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Dec 2027, 36 months after the start.

Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 36 months is above that.

Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 13, 2024
First posted
Mar 20, 2024
StartActual
Dec 29, 2024
Primary completionEst.
Dec 31, 2027
CompletionEst.
Jun 30, 2028
Last update
Mar 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06319703
Lead sponsor
NYU Langone Health
Collaborators
Agency for Healthcare Research and Quality (AHRQ)
Responsible party
Sponsor
First posted
Mar 20, 2024
Start date
Dec 29, 2024
Primary completion
Dec 31, 2027 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Mar 9, 2026

Study contacts

Lu Hu, PhD
Contact
Lu.hu@nyulangone.org
646-501-3438
Lu Hu, PhD
principal investigator · NYU School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion